Nature Communications · 2018 · 135 citations · 18 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceDrug DesignDrug DiscoveryAntibiotic ResistanceAntimicrobial PeptidesNonribosomal Peptide BiosynthesisPeptide ChemistryPeptide Drug DiscoveryResistance In Gram-negative BacteriaAntibacterial PeptidesAntibiotic DiscoveryCationic Antimicrobial PeptidesCationic PeptidesDrug-resistant PathogensNonribosomal Peptide AntibioticsNonribosomal PeptidesNovel Antibacterial Drug Discovery
The worldwide prevalence of infections caused by antibiotic-resistant Gram-negative bacteria poses a serious threat to public health due to the limited therapeutic alternatives. Cationic peptides represent a large family of antibiotics and have attracted interest due to their diverse chemical structures and potential for combating drug-resistant Gram-negative pathogens. Here, we analyze 7395 bacterial genomes to investigate their capacity for biosynthesis of cationic nonribosomal peptides with activity against Gram-negative bacteria. Applying this approach, we identify two novel compounds (brevicidine and laterocidine) showing bactericidal activities against antibiotic-resistant Gram-negative pathogens, such as Pseudomonas aeruginosa and colistin-resistant Escherichia coli, and an apparently low risk of resistance. The two peptides show efficacy against E. coli in a mouse thigh infection model. These findings may contribute to the discovery and development of Gram-negative antibiotics.
18
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations
Cytoscape 2.8: new features for data integration and network visualization
Michael Smoot, Keiichiro Ono, Johannes Ruscheinski et al. · Bioinformatics · 2010 · 5K citations · Full text
Antibiotic resistance—the need for global solutions
Ramanan Laxminarayan, Adriano Dusé, Chand Wattal et al. · The Lancet Infectious Diseases · 2013 · 4.4K citations · Full text
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang, David Bikard, David Cox et al. · Nature Biotechnology · 2013 · 2.5K citations
DrugBank 4.0: shedding new light on drug metabolism
Vivian Law, Craig Knox, Yannick Djoumbou-Feunang et al. · Nucleic Acids Research · 2013 · 2.1K citations · Full text